Correlation Between CHINA DEVELOPMENT and Icares Medicus

Can any of the company-specific risk be diversified away by investing in both CHINA DEVELOPMENT and Icares Medicus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHINA DEVELOPMENT and Icares Medicus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CHINA DEVELOPMENT FINANCIAL and Icares Medicus, you can compare the effects of market volatilities on CHINA DEVELOPMENT and Icares Medicus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHINA DEVELOPMENT with a short position of Icares Medicus. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHINA DEVELOPMENT and Icares Medicus.

Diversification Opportunities for CHINA DEVELOPMENT and Icares Medicus

-0.74

Correlation Coefficient

CHINA DEVELOPMENT  Icares Medicus

Pay attention - limited upside

The 3 months correlation between CHINA and Icares is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding CHINA DEVELOPMENT FINANCIAL and Icares Medicus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icares Medicus and CHINA DEVELOPMENT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHINA DEVELOPMENT FINANCIAL are associated (or correlated) with Icares Medicus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icares Medicus has no effect on the direction of CHINA DEVELOPMENT i.e., CHINA DEVELOPMENT and Icares Medicus go up and down completely randomly.

Pair Corralation between CHINA DEVELOPMENT and Icares Medicus

Assuming the 90 days trading horizon CHINA DEVELOPMENT FINANCIAL is expected to generate 0.16 times more return on investment than Icares Medicus. However, CHINA DEVELOPMENT FINANCIAL is 6.25 times less risky than Icares Medicus. It trades about 0.14 of its potential returns per unit of risk. Icares Medicus is currently generating about 0.01 per unit of risk. If you would invest  675.00  in CHINA DEVELOPMENT FINANCIAL on September 25, 2024 and sell it today you would earn a total of  109.00  from holding CHINA DEVELOPMENT FINANCIAL or generate 16.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CHINA DEVELOPMENT FINANCIAL  vs.  Icares Medicus

CHINA DEVELOPMENT

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CHINA DEVELOPMENT FINANCIAL are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, CHINA DEVELOPMENT is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Icares Medicus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Icares Medicus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with CHINA DEVELOPMENT and Icares Medicus

The main advantage of trading using opposite CHINA DEVELOPMENT and Icares Medicus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHINA DEVELOPMENT position performs unexpectedly, Icares Medicus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icares Medicus will offset losses from the drop in Icares Medicus' long position.

The idea behind CHINA DEVELOPMENT FINANCIAL and Icares Medicus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.